Meeder Asset Management Inc Adverum Biotechnologies, Inc. Transaction History

Meeder Asset Management Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$2.08 - $3.6 $14,304 - $24,757	-6,877 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$3.36 - $10.56 $11,588 - $36,421	3,449 Added 100.61%	6,877 $24,000
Q1 2021 Apr 28, 2021	BUY	$9.26 - $14.36 $31,743 - $49,226	3,428 New	3,428 $35,000
Q4 2020 Feb 09, 2021	SELL	$9.84 - $14.26 $11,729 - $16,997	-1,192 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$10.3 - $21.64 $18,076 - $37,978	-1,755 Reduced 59.55%	1,192 $12,000
Q2 2020 Aug 11, 2020	BUY	$8.53 - $25.64 $11,157 - $33,537	1,308 Added 79.8%	2,947 $62,000
Q1 2020 May 15, 2020	BUY	$7.98 - $16.32 $4,125 - $8,437	517 Added 46.08%	1,639 $16,000
Q4 2019 Feb 13, 2020	SELL	$5.12 - $12.22 $7,715 - $18,415	-1,507 Reduced 57.32%	1,122 $14,000
Q3 2019 Oct 17, 2019	SELL	$5.24 - $15.89 $42,260 - $128,152	-8,065 Reduced 75.42%	2,629 $14,000
Q2 2019 Aug 05, 2019	BUY	$5.1 - $11.89 $42,987 - $100,220	8,429 Added 372.14%	10,694 $127,000
Q1 2019 Apr 16, 2019	SELL	$3.03 - $6.02 $2,217 - $4,406	-732 Reduced 24.42%	2,265 $12,000
Q4 2018 Jan 17, 2019	BUY	$2.87 - $5.92 $7,241 - $14,936	2,523 Added 532.28%	2,997 $9,000
Q3 2018 Nov 02, 2018	BUY	$4.5 - $7.6 $2,133 - $3,602	474 New	474 $0
Q1 2018 May 03, 2018	SELL	$3.65 - $7.95 $5,642 - $12,290	-1,546 Closed	0 $0
Q3 2017 Oct 20, 2017	BUY	$2.45 - $3.65 $3,787 - $5,642	1,546	1,546 $6,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.